Event Overview
Friday, January 22, 2027
8:00 AM – 1:00 PM – Food, Drug and Cosmetic Law Section MCLE Program (Virtual)
FDA Regulatory Highlights and Inter-Agency Interactions with the USPTO and SEC
- Trademark /AFP case about bringing products in from other countries to save money for US prescriptions – Gilead v. Meritain (4th Circuit Aug. 2026)
- Skinny Labeling Supreme Court update – Hikma v. Amarin (S.Ct. 2026)
- Mifepristone update / REMS Question
- FDA/SEC MOU and impact on investor communications/PRs and class actions
- Food Safety issues (salmonella everywhere, infant formula metal and more) and GRAS/E requiring preapproval (not self-affirmed).